Reactogenicity, Safety and Immunogenicity of Booster Dose of Vaccines Against SARS-CoV-2 in Chile
Latest Information Update: 04 Aug 2023
At a glance
- Drugs AZD 1222 (Primary) ; SARS-COV-2 vaccine-inactivated-Sinovac-Biotech (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- Acronyms REFUERZO
- 13 Aug 2021 New trial record